Suppr超能文献

开发一种基于微乳剂的制剂以提高难溶性药物的利用率。

Development of a microemulsion-based formulation to improve the availability of poorly water-soluble drug.

作者信息

Abd-Allah F I, Dawaba H M, Ahmed A Ms

机构信息

Department of Pharmaceutics & Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt.

出版信息

Drug Discov Ther. 2010 Aug;4(4):257-66.

Abstract

The objective of our investigation was to design a thermo-dynamically stable microemulsion formulation of the model drug piroxicam with minimum surfactant concentration in order to improve its solubility. The solubility of piroxicam in different oils was examined. Effects of the co-surfactant:surfactant ratio and water content on microemulsion formulation were evaluated. Phase studies were performed for systems composed of oleic acid as the oil phase, Tween-80 as surfactant, and propylene glycol as co-surfactant at a constant percentage of water to elucidate the effect of microemulsion components on the area of microemulsion formulation. The viscosity and conductivity of certain microemulsion formulations were examined as a function of water dilution. The results showed that oleic acid, Tween-80, and propylene glycol resulted in the highest solubilization of piroxicam. The amount of water that was successfully incorporated into a microemulsion system was directly proportional to the co-surfactant:surfactant ratio and inversely proportional to the percentage amount of the oil phase present in the system. Microemulsion systems displayed changes in their viscosity and conductivity upon water dilution. The pre-microemulsion systems could be used as solvents to provide enhanced solubilizing capacity and stabilization for the solubilized drug. These systems could be loaded with the drug and stored in their original form in order to produce a microemulsion containing the drug in situ upon aqueous dilution. The incorporation of piroxicam in microemulsion formulations led to enhancement of the piroxicam release profile by allowing constant and regular in vitro release as well as reducing piroxicam's particle size to that suited to a microemulsion. Thus, the usage of a microemulsion technique led to improvement in piroxicam availability, suggesting the potential for technique's use as a topical vehicle for piroxicam delivery.

摘要

我们研究的目的是设计一种热力学稳定的模型药物吡罗昔康微乳制剂,使其表面活性剂浓度最低,以提高其溶解度。研究了吡罗昔康在不同油中的溶解度。评估了助表面活性剂与表面活性剂的比例以及含水量对微乳制剂的影响。以油酸为油相、吐温80为表面活性剂、丙二醇为助表面活性剂,在水的比例恒定的情况下,对体系进行相研究,以阐明微乳成分对微乳制剂面积的影响。研究了某些微乳制剂的粘度和电导率随水稀释的变化。结果表明,油酸、吐温80和丙二醇对吡罗昔康的增溶效果最佳。成功掺入微乳体系中的水量与助表面活性剂与表面活性剂的比例成正比,与体系中油相的百分比成反比。微乳体系在水稀释时粘度和电导率会发生变化。微乳前体系可用作溶剂,为溶解的药物提供增强的增溶能力和稳定性。这些体系可以装载药物并以原始形式储存,以便在水稀释时原位产生含药微乳。将吡罗昔康掺入微乳制剂中,通过实现恒定且规律的体外释放以及将吡罗昔康的粒径减小至适合微乳的尺寸,从而增强了吡罗昔康的释放曲线。因此,微乳技术的应用提高了吡罗昔康的利用率,表明该技术作为吡罗昔康局部给药载体具有潜在应用价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验